4//SEC Filing
Bell John K 4
Accession 0001213900-19-011876
CIK 0001498382other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:17 PM ET
Size
5.2 KB
Accession
0001213900-19-011876
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Other
Common Stock
2019-06-28+29→ 9,701 total(indirect: Held by Onbelay Capital Inc.)
Footnotes (2)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001569585
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:17 PM ET
- Size
- 5.2 KB